Piperine derivatives as potential inhibitors of Survivin: An in silico molecular docking
- 1 August 2015
- journal article
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 63, 219-227
Abstract
No abstract availableKeywords
Funding Information
- Isfahan University
- Iran National Science Foundation (93013717)
- National Elites Foundation
This publication has 19 references indexed in Scilit:
- Survivin as a Preferential Target for Cancer TherapyInternational Journal of Molecular Sciences, 2014
- Treat cancers by targeting survivin: Just a dream or future reality?Cancer Treatment Reviews, 2013
- Withanone as an inhibitor of survivin: A potential drug candidate for cancer therapyJournal of Biotechnology, 2013
- Recognition of Smac‐mimetic compounds by the BIR domain of cIAP1Protein Science, 2010
- Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancyMolecular Cancer Therapeutics, 2007
- Survivin as a target for new anticancer interventionsJournal of Cellular and Molecular Medicine, 2005
- The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancerSeminars in Cancer Biology, 2004
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53Journal of Clinical Investigation, 2001
- Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangementNature Structural & Molecular Biology, 2000